Fundamentals of Research in Imaging and Theranostics Part 2
2025-03-01 08:00 - 2027-03-30 17:00 (Europe/Vienna)
UEMS EACCME has granted the accreditation of 4.5 CME credits for this event.

This online course is part of a longer line of research methodology which is aimed at providing interested participants with information about the preclinical development and clinical translation, as well as the design, conductance and reporting of clinical research trials, with a specific emphasis on radiopharmaceuticals for both diagnostic and therapeutic applications.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

For phase I/II clinical studies with radiopharmaceuticals to understand:

The principles of technical realisation of the study including assessment of safety of investigational medicinal product

The statistical considerations, including the estimation of number of subjects to be enrolled

The regulatory requirements for performing clinical studies with radiopharmaceutical with special focus on diagnostic radiopharmaceuticals and to summarise the particularities of these studies

The ethical and medical considerations in common and vulnerable populations

The principles of preparing the clinical study protocol

The objectives, endpoints and outcome measures

The principles of patient selection, inclusion and non-inclusion criteria

The principles of establishment of the standard of truth, the role of the comparator, superiority/non-inferiority/equivalence(?) studies) & practical examples

Target Audience

Personnel involved in designing and/or performing phase I/II clinical research with diagnostic radiopharmaceuticals (e.g. nuclear medicine physicians, pharmacists, physicists, nurses, technologist, administrative staff).

Personnel involved in assessment of the ethical, medical and methodologic aspects of phase I/II research protocols with diagnostic radiopharmaceuticals.

All professionals interested in phase I/II clinical research with diagnostic radiopharmaceuticals

Faculty

Chiara GranaSpeaker

Bart de KeizerSpeaker

Caroline StokkeSpeaker

Jean-Noel TalbotSpeaker

Luisa Roldao PereiraSpeaker

John Andrei IagaruSpeaker

Sona BalogovaSpeaker

Advantages of Long-Axial Field-of-View PET in Inflammation and Infection Imaging
2025-03-07 13:30 - 14:30
Long axial field of view (LAFOV) PET/CT is the latest development in PET instrumentation. This webinar will provide an overview of the clinical opportunities and applications of LAFOV PET in inflammation and infection imaging.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Attendees will be able to describe the main advantages of LAFOV PET in patients with inflammatory and infectious disorders.

Attendees will be able to understand how the increased sensitivity of LAFOV PET/CT allows for faster scanning and/or an important reduction in injected activity, and how it also enables dynamic whole-body PET imaging, studying molecular interactions between organ systems and even delayed imaging.

Attendees will be able to see that ultrafast imaging can facilitate imaging of new patient groups such as critically ill patients, patients admitted to intensive care with persistent infection or children without sedation.

Target Audience

Nuclear Medicine Physicians, Residents, Technologists

Faculty

Joyce van SluisSpeaker

Lars GormsenSpeaker

Andor GlaudemansSpeaker

Oliver GheysensModerator

Event Overview

Cardiac Amyloidosis Imaging: History, Status Quo and Outlook
2025-03-20 09:00 - 2025-03-21 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
This course provides a comprehensive overview of the multimodality diagnosis of cardiac amyloidosis. Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. Imaging modalities will include a focus on echocardiography, cardiac MRI, SPECT, and PET, with discussion of the various tracers available. It will be elaborated when which of the different imaging modalities can be used appropriately and multimodality concepts will also be discussed. The course content will be developed using numerous case examples. Furthermore, the course participants should solve cases independently and discuss them with the other course participants.

Register nowRegistrations are closed. Please contact us at esmit@eanm.org if you are still interested in signing up for the course.

Learning Objectives

Gain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.

Gain a deep insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.

Become familiar with the various imaging modalities available for the diagnosis of cardiac amyloidosis.

To learn the appropriate use of diagnostic options in cardiac amyloidosis (keyword: diagnostic algorithm).

To independently make the correct diagnosis of cardiac amyloidosis on the basis of case studies.

To learn the possibilities of quantification of SPECT and PET.

Target Audience

Nuclear physicians, cardiologists, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics.

ProgrammeView the Programme

Faculty

Stephan NekollaSpeakerMunich, Germany

Raffaella CalabrettaSpeakerVienna, Austria

Carmela NappiSpeakerNaples,Italy

Dietrich BeitzkeSpeakerVienna,Austria

Michael PoledniczekSpeakerVienna,Austria

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Theranostic Training: Practical and Methodological Concepts
2025-03-28 13:30 - 14:30
This webinar aims to introduce the concept of theranostics and provide an overview of its potential. Participants will gain an understanding of how our technological competencies contribute to and enhance theranostic processes, and how we can leverage these strengths in practice.

Please note that the webinar will be recorded, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform, under the webinar title. A handout of the presentation materials will also be available on the platform.

Register nowEnroll in the live webinar now for free! Register now

Learning Objectives

Attendees will understand the concept of theranostics and its significance in modern healthcare.

Attendees will explore the foundational technologies behind theranostics and learn how departments can be organized to integrate theranostic procedures.

Attendees will gain insights into the perspectives of physicians and technologists on theranostics and how these disciplines collaborate to deliver optimal patient outcomes.

Target Audience

Technologists, Nurses, Physicists

Faculty

Riccardo LaudicellaSpeaker

Daniela FonsecaSpeaker

Angelo CardosoModerator

Conrad-Amadeus VoltinModerator

Event Overview

Radioiodine-Refractory Thyroid Cancer - Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?
2025-04-04 13:30 - 14:30
This webinar explores the perspectives on radiorefractory thyroid cancer through two presentations. In the first talk the speaker challenges current diagnostic frameworks and proposes a new vision that better reflects the evolving understanding of refractory thyroid cancer. The second presentation offers a comprehensive review of emerging approaches to restore iodine avidity in radiorefractory thyroid cancer, highlighting recent clinical trials, molecular targeting techniques, and potential promising combination therapies.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

To evaluate the current definition of radiorefractory thyroid cancer and identify its limitations in clinical practice

To learn new insights for radiorefractory thyroid cancer definition and their potential impact on treatment decisions

To learn current evidence-based redifferentiation strategies for restoring iodine avidity in radiorefractory thyroid cancer

To improve knowledge of redifferentiation mechanisms to develop personalized treatment plans for patients with radiorefractory thyroid cancer

Target Audience

Nuclear Medicine physicians, Endocrinologist, Oncologist

Faculty

Petra PetranovicSpeaker

Michael KreisslSpeaker

Luca GiovanellaModerator

Event Overview

Treatment of Metastatic Bone Pain Using Bone-Seeking Agents
2025-04-10 09:00 - 2025-04-11 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
Internal radiotherapy with bone-seeking agents is effective in delivering high doses of radiation to widespread metastatic bone lesions and may limit the radiation absorbed dose to healthy tissue. Beta emitter have long been preferred agents for bone pain palliation. The approval of 223Ra and data showing a prolonged survival with alpha emitter are favored in bone pain palliation. Unfortunately, we do not have good data on the survival after treatment with beta emitters. In the face-to-face course we will discuss the pathophysiology of bone pain to understand the principle of therapeutic effect of bone seeking agents. Dosimetry is essential to increase the dose to the tumor by limiting of severe side effects. All the focus is on the alpha emitters only, based on the poor data about survival data for the beta emitters. The future of therapy in Nuclear Medicine is the combination with other agents to improve the therapeutic effect, e.g. chemotherapy, immunotherapy or anti-androgen therapy.

Register nowClick on the button to sign up for the course. Register now

Learning Objectives

Pathophysiology and medical treatment of bone pain

Pro/con alpha/beta emitters

Performing of dosimetry

Combination treatment to improve the therapeutic effect

Target Audience

Nuclear medicine physician, junior or senior, with an interest in treatment

ProgrammeView the Programme

Faculty

Knut LiepeSpeakerFrankfurt (Oder), Germany

Tatiana LouroSpeakerLisbon, Portugal

Giulia SantoSpeakerCatanzaro, Italy

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging
2025-04-25 00:00 - 2026-04-25 23:59 | Online
Breast cancer remains the most frequently diagnosed cancer and the leading cause of cancer-related death in women worldwide. Despite significant advancements in imaging and treatment, clinical practice remains heterogeneous across institutions and disciplines. Molecular imaging has a pivotal role in breast cancer care, from diagnosis to recurrence assessment. To address these discrepancies and define the future direction of imaging in breast cancer, the European Association of Nuclear Medicine (EANM) devoted its 6th Focus Meeting to this topic, under the following motto “Shaping the Future of Breast Cancer Care with Molecular Imaging”.

The aims of this project were:

To define the role of imaging in breast cancer, particularly the utility of nuclear medicine techniques in different clinical settings (including initial systemic staging, assessment of response to therapy, and detection of recurrence).

To reach a multidisciplinary consensus on the current state of the art in nuclear medicine imaging in breast cancer.

To generate expert recommendations on how best to guide professionals in their clinical decisions, beyond the existing guidelines.

To identify knowledge gaps and topics with lack of scientific evidence for potential future studies.

The recordings in this course are sponsored by Novartis.

Register nowEnrol in the online course now for free! Register now

Faculty

Isabel T. RubioSpeaker

Frederique Penault LlorcaSpeaker

Thiemo van NijnattenSpeaker

Elizabeth DibbleSpeaker

Tessa BuckleSpeaker

Katja Pinker DomenigSpeaker

Sofia Carrilho-VazSpeaker

Martina Bašić-KoretićSpeaker

David GroheuxSpeaker

Gary UlanerSpeaker

Geraldine GebhartSpeaker

Wolfgang WeberSpeaker

Valeria RomeoSpeaker

Alessandra GennariSpeaker

Karolien GoffinSpeaker

Nadia HarbeckSpeaker

Pascal BaltzerSpeaker

Michel van KruchtenSpeaker

Gary Cook Speaker

Paola Anna ErbaSpeaker

Joana M RibeiroSpeaker

Carolien SchröderSpeaker

Ritse MannSpeaker

Philipp BackhausSpeaker

Malene Gubbe Hildebrand Speaker

Fatima CardosoSpeaker

Antoinette AttardSpeaker

Francesco SchnettiniSpeaker

Sofia RiveraSpeaker

Event Overview

Highlights of Focus Meeting 6: Shaping the Future of Breast Cancer Care with Molecular Imaging (pre-recorded)
2025-04-25 13:30 - 14:30
more information coming soon

Register nowEnrol in the live webinar now for free! Register now

Faculty

Speaker

Speaker

Speaker

Event Overview

Gynaecological Malignancies
2025-05-01 00:00 - 23:59 | Online
UEMS EACCME has granted the accreditation of 3 CME credits for this event.

The present course aims to describe the current status, in terms of diagnosis and therapy for gynecological cancers. All the gynecological malignancies (i.e., ovary cancer, endometrial cancer, cervical and vaginal cancer) will be evaluated from the oncological and from diagnostic point of view, with a major emphasis on the role of nuclear medicine, both in diagnosis and therapy.

The speakers are specialists in oncology, radiology and nuclear medicine with a clinical experience in gynecological cancer and will provide some examples that can be found in every day clinical practice.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

Target Audience

Learn about the current available therapies useful for the treatment of gynecological cancer;

Understand the correct diagnostic flow-chart for the management of patients affected by gynecological cancer;

Describe the potential future perspectives in nuclear medicine to face gynecological cancer, from a diagnostic and therapeutical point of view

Oncologists, Radiologists, Nuclear Medicine Physicians, Technicians, Endocrinologists, Gynecologists

ProgrammeClick to see the full event programme. View the Programme

Faculty

Cristina FerrariNuclear Medicine, Italy

Giulia TascaOncology, Italy

Teresa Margarida CunhaRadiology, Portugal

Helen Clare AddleyRadiology, United Kingdom

Desiree Deandreis Nuclear Medicine, France

Ora Israel Nuclear Medicine, Israel

Ozgul EckmekciogluNuclear Medicine, Turkeye

Henrique NabaisGynaecology, Portugal

Monica PiresGynaecology, Portugal

Registration Details

Registration FeeMode of Payment

Course Fee € 300.- + Local VAT Rate

Credit card via the ESMIT eLearning store

Cheques will not be accepted.

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once paid, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

ESMO-EANM Course on Diagnostic and Therapeutic Applications of Nuclear Medicine in Oncology
2025-05-06 00:00 - 2025-05-07 23:59
Learning Objectives

To get an updated analysis of the diagnostic and therapeutic applications of nuclear medicine in oncology

To provide a knowledge of principles of both nuclear medicine modalities and systemic oncologic therapies in advanced trainees and specialists in oncology and nuclear medicine

To provide an educational framework for in-depth analysis of the combined diagnostic/therapeutic strategies (theranostics) in oncology and scientific interaction between oncology and nuclear medicine experts

To foster interdisciplinary exchange and collaboration in both nuclear medicine imaging and nuclear medicine treatment applications

Find out moreMore information about the course, including registration, can be found on the ESMO website Find out more

Introducing Dosimetry in the Clinical Setting
2025-05-09 13:30 - 14:30
This course presents and discusses the requirements and methods to enable and perform personalized dosimetry in nuclear medicine therapy.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

The aim of this course is to provide tools and methods to implement personalized dosimetry in a clinical setup.

Target Audience

Nuclear medicine clinicians and medical physicists

Suggested Readings

“EANM enabling guide: how to improve the accessibility of clinical dosimetry.” Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry

Click Here

Faculty

Jonathan GearSpeaker

Pablo Mínguez GabiñaSpeaker

Eivor HernesSpeaker

Silvano GnesinModerator

Event Overview

CANCELLED: Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease
2025-05-15 09:00 - 2025-05-16 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
More information coming soon

Register nowThis course is cancelled.

Learning Objectives

Target Audience

More information coming soon

More information coming soon

ProgrammeComing soon View the Programme

Faculty

Speaker

Speaker

Speaker

Speaker

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks on each Course Day

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

AD-LEARN Mini-course for Residents: How to Start Reading Brain Scans in Neurocognitive Disorders?
2025-05-19 08:00 - 2025-05-20 12:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
The course aims to provide the participants with basic knowledge regarding nuclear and molecular medical imaging in the neurological field. In particular, cerebral SPET and PET will be addressed.

Register now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna, here is your chance to follow the course live online! Register now

Learning Objectives

Clinical introduction and positioning where imaging is indicated: The aim is to understand the main indications of cerebral SPET and PET methods and the patient’s preparation before the examination.

Primer course: how to read a brain SPECT study: the aim is to understand how to acquire, reconstruct, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.

Primer course: how to read an FDG-PET brain study: the aim is to understand how to acquire, reconstruct, format and read an FDG brain PET/CT. The main clinical patterns will also be presented.

Peer-learning with tips and tricks, and case presentation: the aim is to understand how to acquire, reconstruct, format and read a perfusion and receptorial brain SPET and SPET/CT. The main clinical patterns will also be presented.

Target Audience

Nuclear medicine specialists with little or no experience in reading SPET and PET neurological imaging.

ProgrammeView the Programme

Faculty

Igor YakushevSpeakerMunich, Germany

Stelvio SestiniSpeakerPrato, Italy

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee Registration for this course is free, but we will charge a €100 fee to book your seat, which will be reimbursed upon attendance

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card. Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

AD-LEARN mini-course for Techs and Nurses: The Value and Challenges of Brain SPECT in PET in Neurocognitive Disorders
2025-05-20 13:00 - 2025-05-21 17:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
The course is designed for Technologists and Nurses to enhance their expertise in applying radiopharmaceuticals for AD and MCI diagnosis in nuclear medicine. Participants will learn radiation protection principles, radiolabelling procedures, and waste management. The program also covers novel PET radiotracers for molecular diagnosis of neurocognitive disorders. Additionally, the course addresses patient and caregiver management and the role of Technologists in operating SPECT and PET equipment for AD and MCI imaging. Led by European experts, the interactive sessions will allow participants to engage in discussions and ask questions, fostering a deeper understanding of the subject.

Register now for the VIRTUAL EXPERIENCEIn case you cannot join us in Vienna, here is your chance to follow the course live online! Register now

Learning Objectives

To gain knowledge about the methods and principles of radiolabelling and waste management with a special focus on radiation protection

To become educated in terms of radiotracers used in neurocognitive disorders diagnostic management

To learn the radiolabelling procedures’ adverse events basics and errors’ prevention

To be informed about the principles and importance of appropriate cooperation between medical professional, patient and their caregiver before, during and after SPECT and PET neurocognitive diseases’ imaging

To understand the roles and responsibilities of Technologists and Nurses in the nuclear medicine neurocognitive diseases’ diagnostic management

To improve the skills in terms of the interdisciplinary medical team collaboration focusing on Technologists/Nurses and other medical specialists’ cooperation.

Target Audience

Technologists and Nurses

ProgrammeView the Programme

Faculty

Markus KӧhnerSpeakerErlangen, Germany

Daniela FonsecaSpeakerLondon, UK

Valentina MautoneSpeakerMeldola, Italy

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee Registration for this course is free, but we will charge a €100 fee to book your seat, which will be reimbursed upon attendance

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Parathyroid Imaging (Self-paced)
2025-06-01 00:00 - 23:59 | Online
UEMS EACCME has granted the accreditation of 2.5 CME credits for this event.

This self-paced online course will offer a comprehensive exploration of the anatomy, physiology, and diagnostic tools related to parathyroid glands disorders. The course will cover a range of topics, including the regulation of parathyroid hormone (PTH) secretion and his mechanisms of action, etiology, clinical manifestations, and notably the diagnostic approaches ( laboratory and imaging), and treatment modalities especially concerning hyperparathyroidism.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

Attendees will gain insights into structure and function of the parathyroid glands, earning about etiology, clinical manifestations, diagnostic approaches focused on nuclear medicine and radiological techniques and treatment modalities of hyperparathyroidism. Through lectures, and case studies, participants will acquire the knowledge and skills necessary to diagnose and manage parathyroid disorders.

Target audience

This course is designed for Nuclear Medicine Physicians, Endocrinologists and Radiologists.

ProgrammeClick to see the Preliminary Programme. Please note, that it may be subject to change at any time. Programme

Faculty

Luca GiovanellaZurich, Switzerland

Murat TuncelAnkara, Türkiye

Michael KreisslMagdeburg, Germany

Petra PetranovicZagreb, Croatia

Registration Details

Registration Fee

Course Fee Free

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

eLearning Course StoreEnter the course store, make your selection and check out.

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once enrolled, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

Bringing Alpha Therapies into Clinical Practice
2025-06-01 00:00 - 23:59 | Online
UEMS EACCME has granted the accreditation of 3 CME credits for this event.

This online course offers a comprehensive introduction to alpha therapy in nuclear medicine, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting radioisotopes to deliver lethal doses of radiation directly to cancer cells while sparing healthy tissues. It is highly efficient and lately increasingly explored for scientific purposes in the oncologic domain . With this course we aim at bringing Alpha Therapies into clinical practice through various, relevant presentations. A panel of experts and EANM members will update you on the type of alpha-emitting radioisotopes available, describing all important steps required for production and radiopharmaceutical development. The advantages, but also the challenges related to the use of Alpha therapy will amply be discussed and supported by clinical examples. You will be initiated in the existing and ongoing therapeutic trials, with the best yet to come. Dosimetry will play a pivotal role in this course, underlying its role in clinical practice. Finally, The Alphamet project will be presented, allowing you to get updated with the latest insights from Theranostics.

RPH

Targeted Alpha Therapy (TAT) represents a cutting-edge advancement in cancer treatment, harnessing the potent, cell-killing power of alpha particles to precisely destroy malignant cells while minimizing damage to surrounding healthy tissue. This part of the course course explores the transformative potential of TAT, highlighting its exceptional potency, unique ability to overcome radio-resistance, and its role in modern theranostics. You’ll gain insight into the selection of optimal alpha-emitting radionuclides, the biological advantages of short-range high-energy emissions, and the complex challenges involved in the development, production, and clinical translation of these innovative therapies. Join us to deepen your knowledge and be part of the future of targeted radiopharmaceuticals in oncology.

Oncology

In this part of the course, participants will explore the main advantages of alpha-emitting radionuclides in oncology, while also gaining an understanding of the clinical challenges associated with their use. You will become familiar with the key clinical aspects of Alpha-Therapy, supported by real-world perspectives and case insights. The course also highlights current and upcoming therapeutic trials, providing valuable knowledge on the future direction of this rapidly evolving field.

Dosimetry

Participants will begin by exploring the basic concepts of dosimetry with alpha emitters, highlighting key differences from beta emitter dosimetry. The course then delves into the clinical relevance of alpha dosimetry, demonstrating how accurate dose assessments can inform and optimize the management of patients undergoing treatment with alpha radiotherapeutics. In addition, the course presents the Alphamet project, a major European initiative that addresses the specific metrological challenges associated with targeted alpha therapies. By examining the goals and contributions of Alphamet, learners will gain insight into how this research supports the safe and effective integration of alpha therapy into routine clinical practice.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

Target Audience

To gain an overview of the main advantages of Alpha-radionuclides

To learn about the challenges of alpha emitters, complex production; transport issues, waste management and handling

To get insights on radiobiology: radiotoxicity & effectiveness

To have a comprehensive review of research candidates

To provide an overview of the main advantages when using Alpha-Therapy in clinical practice

To learn about the clinical challenges when using Alpha-Therapy

To get insights into current and future trials focusing on Alpha-Therapy

To learn the most basic aspects about dosimetry of alpha emitters showing the main differences with dosimetry of beta emitters

To learn how dosimetry results could be used in the management of patients treated with radiopharmaceuticals that include alpha emitters

To learn on the Alphamet project, which addresses the unique and unmet metrological challenges of targeted alpha therapies, contributing to their safe and optimised implementation into routine clinical practice

Nuclear medicine physicians, radiologists, medical oncologists, urologists, radiation oncologists, medical physicists, biologists, researchers

Radiochemists, radiopharmacists, physicists, medical physicists, biologists

ProgrammeClick to see the full event programme. View the Programme

Faculty

Dana NiculaeSpeaker

Marianna TosatoSpeaker

Pablo Mínguez GabiñaSpealer

Ana Denis-BacelarSpeaker

Emma AnaheimSpeaker

Wolfgang FendlerSpeaker

Mike SathekgeSpeaker

Joe O’SullivanSpeaker

Janke KleynhansSpeaker

Mathias ZacherlSpeaker

Daniela Oprea-LagerSpeaker

Registration Details

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once registered, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

GMP for Radiopharmaceuticals
2025-06-05 09:00 - 2025-06-06 16:00 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
The GMP guidelines provide minimum requirements that a manufacturer of radiopharmaceuticals must meet to assure that their products are consistently high in quality, from batch to batch, for clinical use.

The Basics of cGMP is a 2 days on-site ESMIT course, providing guidance through EU-cGMP regulation for manufacturing, testing, and quality assurance of radiopharmaceuticals in order to ensure that a manufactured product is safe for human use. Principles regarding facilities, equipment qualification, controlled environmental conditions, processes and methods validation, standard operation procedures and user specific requirement, risk assessment, and specifications will be detailed. Also, the main components of investigational new drug and marketing authorisation dossiers will be discussed.

Register nowThe registration is closed. Please contact us at esmit@eanm.org if you still want to register.

Learning Objectives

General knowledge regarding GMP and cGMP for Radiopharmaceuticals principles and guidelines.

Target Audience

Radiopharmacists and radiochemists in translational research, hospital radiopharmacy and radiopharmaceutical production centres.

ProgrammeView the Programme

Faculty

Dana NiculaeSpeakerBucharest, Romania

Philip ElsingaSpeakerGroningen, Netherlands

Antero AbrunhosaSpeakerCoimbra, Portugal

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Cardiac Amyloidosis Imaging: Do We Need Quantification?
2025-06-13 13:30 - 14:30
This webinar provides an overview of the diagnosis of cardiac amyloidosis in nuclear cardiology . Background information on amyloidosis in general is presented and typical disease manifestations are discussed. Furthermore, the significance of cardiac amyloidosis will be discussed in detail and possible therapeutic options will be explained. In this context, the relevance of quantification to characterize disease and how to assess reliably the effects of therapy are presented.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

To gain a insight into the disease of amyloidosis and in particular the cardiac involvement of amyloidosis.

To learn the possibilities of quantification of planar and SPECT studies in amyloidosis

Target Audience

Nuclear physicians, cardiologists, internists and radiologists who are interested in amyloidosis and want to deepen their knowledge of cardiac amyloidosis diagnostics and quantification

Faculty

Federico CaobelliSpeaker

Ian ArmstrongSpeaker

Carmela NappiModerator

Stephan NekollaModerator

Event Overview

Extravascular Administration in Diagnostic and Therapeutic Nuclear Medicine
2025-06-27 13:30 - 14:30
In nuclear medicine, diagnostic as well as therapeutic, radiopharmaceuticals are administered via an intravenous injection, in a majority of the procedures in a blood vessel at the crook of the arm or on the back of the hand. Occasionally, the injection fails, which results in the radiopharmaceutical ending up extravascularly. The consequence of this may be a locally high radiation dose at the injection site, in some situations high enough to cause severe tissue effects on the patient. Thus, it is important to recognize the problem and identify the cause in order to decrease the risk. Furthermore, the management of the situation after such an extravasation must be dealt with thoroughly and this has been the subject of lively debate in recent years. The parameters that have an impact on the radiation dose are among other things, the physical properties of the radionuclide, as well as the activity and volume of the radioactive substance retained in the surroundings of the blood vessel. In the case when most of the administered activity ends up extravascular, the quality of the diagnostic procedure or the effect of the treatment are negatively affected, which must be addressed.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

The aim of this webinar is to highlight the risk and consequences of extravascular administration of radiopharmaceuticals as well as the management of the situation after an extravasation.

Target Audience

Physicists, Physicians, Technologists, Nurses

Faculty

Siria MediciSpeaker

Jochem van der Pol Speaker

Sigrid Leide SvegbornModerator

Event Overview

Alpha Emitters – The Roadmap of the Big Ones!
2025-07-04 13:30 - 14:30
The purpose of this seminar is to provide a comprehensive overview of radionuclide therapy using alpha-emitting isotopes, focusing on their current clinical and preclinical applications. It will explore the unique advantages of alpha emitters, such as their high linear energy transfer and short path length, which allow for precise tumor cell killing with minimal damage to surrounding tissue. The seminar will also address key challenges, including limited availability of suitable alpha-emitting radionuclides, complex radiochemistry, and safety concerns during production and handling. Emphasis will be placed on production routes, chelation strategies, and conjugation chemistry that enable targeted delivery to cancer cells. Finally, the session will critically evaluate the therapeutic potential and limitations of alpha therapy, highlighting areas for future research and clinical translation.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Participants will gain understanding of the advantages of alpha-emitters over beta emitter

Participants will be able to describe and explain challenges arising from applications of alpha-emitters

Target Audience

Radiochemist, Radiopharmacists, nuclear physicians with a research profile, medicinal chemistry researchers

Faculty

Matthias HerthSpeaker

Filipe ElvasSpeaker

Dana NiculaeModerator

Event Overview

Technical Aspects of Parenteral Administration of Radiopharmaceuticals to Oncological Patients
2025-08-29 13:30 - 14:30
For performing the PET/CT examination, the administration of radiopharmaceutical as unavoidable for imaging with PET. Inversely, the administration of contrast agent to improve the quality of CT part of PET/CT as optional. The accurate intravenous administration of diagnostic radiopharmaceutical (and optionally of contrast agent) may be challenging in some cases, in particular in patients with compromised peripheral venous access after several lines of treatments. In order to increase the patient comfort and to simplify the intravenous administration of medicines, several types of long-term venous access have been developed.

Register nowEnrol in the live webinar now for free! Register now!

Learning Objectives

To understand the different types of currently available long-term venous accesses

To understand the principles of safe and correct handling of long-term venous access in patient referred for PET/CT

Target Audience

Nuclear Medicine Professionals

Faculty

Eugenia TrigosoSpeaker

Sona BalogovaSpeaker

Conrad-Amadeus VoltinModerator

Event Overview

NucMed Essentials - MSK Basics
2025-09-01 00:00 - 23:59 | Online
UEMS EACCME has granted the accreditation of CME credits for this event.

Nuclear Medicine Essentials: The Basics of MSK provides a comprehensive introduction to musculoskeletal applications in nuclear medicine, focusing on both diagnostic and therapeutic techniques. Participants will explore the fundamental principles of bone scintigraphy, including its physiological basis, imaging protocols, and wide range of clinical applications, with emphasis on its continued importance in patient care. The course also delves into advanced imaging through NaF PET, highlighting its uptake mechanisms, technical considerations, and growing role in oncology and other clinical contexts. Building on these diagnostic foundations, the course transitions into therapeutic strategies, such as the use of Radium-223 in the treatment of bone metastases, with attention to efficacy, safety, and radioprotection measures.

Beyond theoretical understanding, the program emphasizes practical application and clinical relevance. Learners will gain exposure to cutting-edge research, evidence-based workflows, and therapeutic innovations in the field. Radiosynovectomy for arthritis treatment is presented as an important example of nuclear medicine’s therapeutic scope, with procedural insights and expected outcomes supported by real-world case demonstrations. Departmental video presentations supplement each topic, offering participants a unique opportunity to see workflows and protocols in practice. By the end of the course, attendees will not only understand the fundamentals of musculoskeletal nuclear medicine but also appreciate its evolving role in modern imaging and therapy.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

Target Audience

Understand the fundamentals of bone scan techniques:– Describe the theoretical considerations and acquisition protocols for bone scans.– Explain the clinical applications of bone scans across various pathologies.

Gain insights into NaF PET for bone imaging:– Summarize the theoretical considerations and acquisition protocols specific to NaF PET.– Recognize the essential applications of NaF PET in oncology and other clinical cases.

Explore therapeutic approaches for bone metastases using bone-seeking agents:– Review current theoretical knowledge and recent publications on the treatment of bone metastases.– Identify practical considerations and procedural steps involved in bone-seeking agent therapies.

Learn the application of radiosynovectomy in managing arthritis:– Describe the indications, procedures, and expected outcomes of radiosynovectomy for arthritis treatment.

Apply knowledge through visual and practical insights from real-world clinical settings:– Assess clinical workflows and procedural nuances via department video presentations for each session.

Nuclear Medicine Physicians and Residents

ProgrammeClick to see the full event programme. View the Programme

Faculty

Knut LiepeSpeaker

Jules Zhang-YinSpeaker

Paolo TurcoSpeaker

Registration Details

Registration Fee

Course Fee € 0.-

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once registered, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

Radiation Safety for Oncological Patients before and after Nuclear Medicine Procedures and Radiation Safety of Nursing Staff
2025-09-19 13:30 - 14:30
This webinar will emphasize the critical importance of radiation protection in safeguarding both the occupational health of care providers and the well-being of patients undergoing radionuclide therapy.

It will underscore the necessity of adhering to established guidelines and protocols when handling radioactive materials to ensure safety and treatment efficacy.

Furthermore, the session will explore the role of interprofessional collaboration and continuing education among health care providers in enhancing radiation safety practices. It will also present evidence-based strategies to mitigate patients’ symptoms associated with the adverse effects of radionuclide treatment.

Register now!Enrol in the live webinar now for free! Register now

Learning Objectives

To identify the primary steps for introducing newly hired health care staff to radionuclide therapy protocols and recognize the importance of continuous education in maintaining adherence to institutional safety and procedural standards.

To evaluate various educational methods and strategies used to train health care providers—including nurses, caregivers, seasonal workers, and clinical assistants—in the principles, procedures, and safety protocols of radionuclide therapy.

To demonstrate effective patient education techniques and symptom management strategies for individuals undergoing radionuclide therapy, with attention to minimizing adverse effects and enhancing patient comprehension.

To compare different radiation safety protocols and clinical guidelines associated with Lutathera and radioiodine therapies, with respect to implications for both patients and health care providers.

Target Audience

All health care providers involved in the care of oncological patients undergoing radionuclide treatment in clinical practice

Faculty

Lace MatarloSpeaker

Matthias Hellberg-NaegeleModerator

Sigrid Leide SvegbornSpeaker

Explainable AI
2025-10-24 13:30 - 14:30
The webinar will provide first the fundamentals and basics of explainable artificial intelligence, including the tools for interpretability of machine and deep learning models, as well as the explainability principles. Second, it will provide how these concepts are translated and applied to the development of AI-based models for nuclear medicine applications.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Attendees will be able to understand what are the concepts and methods that define explainable AI, including interpretability tools and algorithms, as well as explainability concepts to translate these to the end-users.

Attendees will be able to discover how these concepts can be used to facilitate the development, adoption and trust for end-users of AI-based models in nuclear medicine applications.

Target Audience

Nuclear medicine physicians, scientists and technologists interested in the application of artificial intelligence in nuclear medicine imaging applications.

Faculty

Neo Christopher ChungSpeaker

Clemens SpielvogelSpeaker

Mathieu HattModerator

Event Overview

Bringing Alpha Therapies into Clinical Practice
2025-10-30 08:00 - 2027-11-30 17:00 | Online
UEMS EACCME has granted the accreditation of 3 CME credits for this event.

This online course offers a comprehensive introduction to alpha therapy in nuclear medicine, with a focus on the fundamental principles and clinical applications of Alpha-Therapy in the fields of Radiopharmaceutical Sciences, Oncology and Dosimetry. Alpha Therapy is a cutting-edge cancer treatment using alpha radiation. It represents a form of targeted radionuclide therapy that uses alpha-emitting radioisotopes to deliver lethal doses of radiation directly to cancer cells while sparing healthy tissues. It is highly efficient and lately increasingly explored for scientific purposes in the oncologic domain . With this course we aim at bringing Alpha Therapies into clinical practice through various, relevant presentations. A panel of experts and EANM members will update you on the type of alpha-emitting radioisotopes available, describing all important steps required for production and radiopharmaceutical development. The advantages, but also the challenges related to the use of Alpha therapy will amply be discussed and supported by clinical examples. You will be initiated in the existing and ongoing therapeutic trials, with the best yet to come. Dosimetry will play a pivotal role in this course, underlying its role in clinical practice. Finally, The Alphamet project will be presented, allowing you to get updated with the latest insights from Theranostics.

RPH

Targeted Alpha Therapy (TAT) represents a cutting-edge advancement in cancer treatment, harnessing the potent, cell-killing power of alpha particles to precisely destroy malignant cells while minimizing damage to surrounding healthy tissue. This part of the course course explores the transformative potential of TAT, highlighting its exceptional potency, unique ability to overcome radio-resistance, and its role in modern theranostics. You’ll gain insight into the selection of optimal alpha-emitting radionuclides, the biological advantages of short-range high-energy emissions, and the complex challenges involved in the development, production, and clinical translation of these innovative therapies. Join us to deepen your knowledge and be part of the future of targeted radiopharmaceuticals in oncology.

Oncology

In this part of the course, participants will explore the main advantages of alpha-emitting radionuclides in oncology, while also gaining an understanding of the clinical challenges associated with their use. You will become familiar with the key clinical aspects of Alpha-Therapy, supported by real-world perspectives and case insights. The course also highlights current and upcoming therapeutic trials, providing valuable knowledge on the future direction of this rapidly evolving field.

Dosimetry

Participants will begin by exploring the basic concepts of dosimetry with alpha emitters, highlighting key differences from beta emitter dosimetry. The course then delves into the clinical relevance of alpha dosimetry, demonstrating how accurate dose assessments can inform and optimize the management of patients undergoing treatment with alpha radiotherapeutics. In addition, the course presents the Alphamet project, a major European initiative that addresses the specific metrological challenges associated with targeted alpha therapies. By examining the goals and contributions of Alphamet, learners will gain insight into how this research supports the safe and effective integration of alpha therapy into routine clinical practice.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

To gain an overview of the main advantages of Alpha-radionuclides

To learn about the challenges of alpha emitters, complex production; transport issues, waste management and handling

To get insights on radiobiology: radiotoxicity & effectiveness

To have a comprehensive review of research candidates

To provide an overview of the main advantages when using Alpha-Therapy in clinical practice

To learn about the clinical challenges when using Alpha-Therapy

To get insights into current and future trials focusing on Alpha-Therapy

To learn the most basic aspects about dosimetry of alpha emitters showing the main differences with dosimetry of beta emitters

To learn how dosimetry results could be used in the management of patients treated with radiopharmaceuticals that include alpha emitters

To learn on the Alphamet project, which addresses the unique and unmet metrological challenges of targeted alpha therapies, contributing to their safe and optimised implementation into routine clinical practice

Target Audience

Nuclear medicine physicians, radiologists, medical oncologists, urologists, radiation oncologists, medical physicists, biologists, researchers

Radiochemists, radiopharmacists, physicists, medical physicists, biologists

ProgrammeClick to see the full event programme. View the Programme

Faculty

Dana NiculaeSpeaker

Emma AnaheimSpeaker

Janke KleyhansSpeaker

Marianna TosatoSpeaker

Wolfgang FendlerSpeaker

Mathias ZacherlSpeaker

Pablo Mínguez GabiñaSpeaker

Mike SathekgeSpeaker

Daniela Oprea-LagerSpeaker

Ana Denis-BacelarSpeaker

Joe O’SullivanSpeaker

myEANM accountLog into your myEANM account or create a new one.

ESMIT eLearningAccess the eLearning platform. You can also navigate to it directly from your myEANM database: ESMIT→ESMIT Registrations

Enroll yourselfFind your desired course under ‘Online Courses’

Enjoy!Once enrolled, you get full access to the course contents on the ESMIT eLearning platform

Event Overview

NucMed Essentials - MSK Basics
2025-11-03 00:00 - 2027-11-30 23:59
UEMS EACCME has granted the accreditation of 5 CME credits for this event.

New ESMIT Learning format: Self-paced online course followed by a live session with the course faculty, where participants are able to ask their questions live!*

Nuclear Medicine Essentials: The Basics of MSK provides a comprehensive introduction to musculoskeletal applications in nuclear medicine, focusing on both diagnostic and therapeutic techniques. Participants will explore the fundamental principles of bone scintigraphy, including its physiological basis, imaging protocols, and wide range of clinical applications, with emphasis on its continued importance in patient care. The course also delves into advanced imaging through NaF PET, highlighting its uptake mechanisms, technical considerations, and growing role in oncology and other clinical contexts. Building on these diagnostic foundations, the course transitions into therapeutic strategies, such as the use of Radium-223 in the treatment of bone metastases, with attention to efficacy, safety, and radioprotection measures.

Beyond theoretical understanding, the program emphasizes practical application and clinical relevance. Learners will gain exposure to cutting-edge research, evidence-based workflows, and therapeutic innovations in the field. Radiosynovectomy for arthritis treatment is presented as an important example of nuclear medicine’s therapeutic scope, with procedural insights and expected outcomes supported by real-world case demonstrations. Departmental video presentations supplement each topic, offering participants a unique opportunity to see workflows and protocols in practice. By the end of the course, attendees will not only understand the fundamentals of musculoskeletal nuclear medicine but also appreciate its evolving role in modern imaging and therapy.

*The live follow-up session will only be held if there is interest – please submit your questions at the dedicated space on our eLearning platform. The date of the live session will be announced in due time.

Save yourself a seatEnter the eLearning store to register for the course. Having trouble? See the short tutorial here. Register now!

Learning Objectives

I. Understand the fundamentals of bone scan techniques:

Describe the theoretical considerations and acquisition protocols for bone scans.

Explain the clinical applications of bone scans across various pathologies.

II. Gain insights into NaF PET for bone imaging:

Summarize the theoretical considerations and acquisition protocols specific to NaF PET.

Recognize the essential applications of NaF PET in oncology and other clinical cases.

III. Explore therapeutic approaches for bone metastases using bone-seeking agents:

Review current theoretical knowledge and recent publications on the treatment of bone metastases.

Identify practical considerations and procedural steps involved in bone-seeking agent therapies.

IV. Learn the application of radiosynovectomy in managing arthritis:

Describe the indications, procedures, and expected outcomes of radiosynovectomy for arthritis treatment.

V. Apply knowledge through visual and practical insights from real-world clinical settings:

Assess clinical workflows and procedural nuances via department video presentations for each session.

Target Audience

Nuclear medicine physicians and residents

Faculty

Knut LiepeSpeaker

Jules Zhang-YinSpeaker

Paolo TurcoSpeaker

Nuclear Medicine-related Highlights from ESMO 2025
2025-11-07 13:30 - 14:30
This ESMO 2025 webinar will cover a range of topics, including the latest advancements treatment options, imaging modalities and performant tracers related to solid and liquid tumors. The focus of this Live event will be the recent advances in solid & liquid tumor treatment, clinical trials and emerging therapies, biomarkers in solid tumors and multidisciplinary approaches. The importance of collaboration among medical oncologists, radiologists, nuclear medicine physicians, pathologists and surgeons will be underlined, based on clinical examples. Challenges and opportunities in immunotherapy for solid tumors will also be addressed, with special attention for personalized treatment plans in specific cancers, like lung cancer, breast cancer, colorectal and prostate cancer.

Please note that the webinar will be recorded, and the recording will be available a few days after the session is over. You can find the recording on the ESMIT E-learning platform, under the webinar title. A handout of the presentation materials will also be available on the platform.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

Attendees will get insight into recent advances in solid/ liquid tumor treatment

Attendees will be familiarized with the latest developments when diagnosing, staging and treating different types of solid and liquid tumors.

Target Audience

Fellows and Medical Specialists in Nuclear Medicine, Radiology, Medical Oncology, Urology, Surgery, Pathology and Radiation Oncology

Faculty

David KerstingModerator

Karolien GoffinSpeaker

Matthias EiberSpeaker

Event Overview

Paediatric Thyroid Cancer
2025-11-14 13:30 - 14:30
This webinar aims to underly the most relevant differences with the adults DCT regarding epidemiology, genetics, pathology, immunoistopathology, diagnostic tools and treatment, especially for RAI theranostic procedure. Additionally, the webinar will also go over the main GL recommendations, as well as present and discuss two emblematic or tricky cases.

Register nowEnrol in the live webinar now for free! Register now

Learning Objectives

The aim of this course is to sensitise the attendees about the correct way to recognise, diagnose and treat DTC in children.

Target Audience

Physicians, residents with special interest on endocrinlogy and endo-oncology, nuclear medicine specialists, nurses and technicians of nuclear medicine units.

Suggested Readings

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. PMID: 25900731; PMCID: PMC4854274.

Lebbink CA, Links TP, Czarniecka A, Dias RP, Elisei R, Izatt L, Krude H, Lorenz K, Luster M, Newbold K, Piccardo A, Sobrinho-Simões M, Takano T, Paul van Trotsenburg AS, Verburg FA, van Santen HM. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022 Nov 29;11(6):e220146. doi: 10.1530/ETJ-22-0146. PMID: 36228315; PMCID: PMC9716393.

Czarniecka A, Woźniak G, Kropińska A, Jarząb B, Handkiewicz-Junak D. Surgical approach to differentiated thyroid cancers (DTC) in children [Specyfika leczenia chirurgicznego zróżnicowanych raków tarczycy (ZRT) u dzieci]. Endokrynol Pol. 2019;70(4):357-366. doi: 10.5603/EP.a2019.0033. PMID: 31489960.

Faculty

Desiree DeandreisSpeaker

Catia OliantiModerator

Livia LamartinaSpeaker

Event Overview

Focus on FDG PET/CT in Inflammatory and Infectious Diseases
2025-11-20 09:00 - 2025-11-21 12:30 | Future Health Lab, Alfred-Adler-Straße 1, Vienna, 1100, Austria
Inflammation comes from the Latin word inflammare, to ignite or to set on fire – we want to ignite your interest in imaging inflammation and infection.

Inflammatory and infectious diseases can be clinically challenging. Many are systemic with highly variable clinical presentations and sometimes vague and non-specific symptoms and findings. Association with implanted material like artificial heart valves, joint or vascular prostheses may hamper imaging or give rise to non-specific findings.

Although the imaging strategy may still be considered unclarified in some settings, [18F]FDG-PET/CT is now established as a key modality in the diagnostic workup of several inflammatory and infectious diseases. The course aims to provide the participants with an overview of the evidence and practical use of [18F]FDG-PET/CT in suspected inflammation and infection and covers the most well-established indications.

Led by European experts, the sessions mix short overview lectures with interactive sessions to allow participants to engage in discussions and exchange experiences on daily practices with each other and the faculty.

Register nowThe course is fully booked. Please contact us at esmit@eanm.org if you would like to be added to the waiting list!

Learning Objectives

To provide general insights into the use of [18F]FDG PET/CT in suspected or manifest inflammation and infection, e.g. patient preparation and protocols

To provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific inflammatory diseases, e.g. vasculitis, polymyalgia rheumatica, other reumatologic diseases, and sarcoidosis

To provide insights into how and when to use [18F]FDG PET/CT in suspected or manifest specific infectious diseases, e.g. fever and inflammation of unknown origin, blood stream infections, osteomyelitis and spondylodiscitis, cardiac and vascular infections

To provide some insights into novel developments with this domain, e.g. FAPI, bacteria-specific tracers, and long axial field of view scanners

To facilitate an open discussion on pro and cons of [18F]FDG PET/CT in suspected or manifest inflammation and infections

Target Audience

Nuclear medicine specialists with basic experience in reading [18F]FDG-PET/CT in inflammatory and infectious diseases.

ProgrammeView the Programme

Faculty

Soren HessSpeakerOdense, Denmark

Olivier GheysensSpeakerBrussels, Belgium

Ayah NawwarSpeakerBristol, UK

Giorgio TregliaSpeakerLugano, Switzerland

Registration Details

Registration FeeMode of PaymentCancellation Policy

Course Fee € 950.-

Registration Fee includes:

Electronic Course Book, including all Slides

Coffee & Lunch Breaks

Registration Fee does NOT include:

Travel to the Venue

Accommodation

Registration fees need to be paid 1 week prior to the event. In case the payment is not received by this deadline, the registration needs to be cancelled. Payment can be settled by Credit Card Cheques will not be accepted

Cancellations must be notified in writing to the EANM Office. Telephone cancellations cannot be accepted. Substitutions will be accepted if the name and e-mail address of the substitute are sent to the EANM Office 4 weeks prior to the event. In the case of cancellation 4 weeks before the course, we will refund you the fee less a € 100,- administration charge. After this date, we cannot grant any refund for cancellations. Any refund will take place after the respective course. EANM will not be held liable for cancellation fees of hotels, airlines or other means of transportation.

Japanese vs. European View on Targeted Radionuclide Therapy
2025-12-01 10:00 - 11:00
This event is a collaboration between ESMIT and JSNM. The aim of the webinar is to compare the approach to targeted radionuclide therapy (TRT) in Japan and in Europe. The webinar will focus on the differences in the TRT environment in Japan vs. Europe, including regulatory science and radiation protection regulation, and more.

Register nowEnrol in the live webinar now for free! Register now

Target Audience

Nuclear Medicine Physicians

Faculty

Tatsuya HigashiSpeaker

Wolfgang FendlerSpeaker

Conrad-Amadeus VoltinModerator

Event Overview
